Skip to main content

Emotion Regulation Trajectories at Ages 3 to 7 Years Tied to ADHD Symptoms at 7 Years

By Lori Solomon HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 27, 2024.

via HealthDay

WEDNESDAY, Nov. 27, 2024 -- Trajectories of emotion regulation across ages 3 to 7 years predict attention-deficit/hyperactivity disorder (ADHD) symptoms, as well as conduct problems, according to a study recently published online in Development and Psychopathology.

Aja Louise Murray, Ph.D., from the University of Edinburgh in the United Kingdom, and colleagues used data from more than 19,000 children in the U.K.-based Millennium Cohort Study to evaluate whether developmental trajectories of emotion regulation across ages 3, 5, and 7 years predict levels of ADHD symptoms, internalizing problems, and conduct problems at age 7 years.

The researchers found that both higher initial levels of and slower reductions in emotion dysregulation across ages 3, 5, and 7 years predicted higher ADHD symptoms, conduct problems, and internalizing problems at age 7 years. Findings were seen in both male and female children.

"Emotion regulation skills are acquired from early in life and are thought to strengthen gradually over childhood. Children, however, acquire these skills at different rates and slower acquisition may serve as a marker for neurodevelopmental and mental health issues," Murray said in a statement. "Our findings suggest that monitoring trajectories of emotion regulation over development could help identify which children are at risk of mental health issues."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

ADHD Drug Treatment Linked to Reduced Rate of Adverse Outcomes

THURSDAY, Aug. 14, 2025 -- Attention-deficit/hyperactivity disorder (ADHD) drug treatment is associated with reduced rates of adverse outcome events, including suicidality...

Current Medical Use of Rx Stimulants for ADHD Up in Teens From 2005 to 2023

TUESDAY, Aug. 5, 2025 -- Among U.S. adolescents, current medical use of prescription stimulants for attention-deficit/hyperactivity disorder (ADHD) increased between 2005 and...

Insomnia Plays a Role in Quality of Life for Patients With ADHD

MONDAY, July 21, 2025 -- Attention-deficit/hyperactivity disorder (ADHD) symptoms are associated with lower quality of life (QoL) in adults, and this association is only partially...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.